Skip to Main Content

Paper Details

Combinatorial biomarker for predicting outcomes to anti-PD-1 therapy in patients with metastatic clear cell renal cell carcinoma.
Cell Rep Med
10
2023
Hematoxylin, PBRM1, TIL, eosin, metastatic clear cell renal cell carcinoma, patients, tumor, tumor-infiltrating immune cells
Author NameAffiliation
Ludmila DanilovaJohns Hopkins University, USA The Bloomberg~Kimmel Institute for Cancer Immunotherapy
Ludmila DanilovaJohns Hopkins University, USA The Bloomberg~Kimmel Institute for Cancer Immunotherapy
Toni K ChoueiriDana-Farber Cancer Institute
  • 1 - 3

Datasets

Release 1.2